• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Mortality and clinical response of patients with bullous pemphigoid treated with rituximab.

作者信息

Yoo D S, Lee J H, Kim S-C, Kim J H

机构信息

Department of Dermatology, Gangnam Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea.

Department of Dermatology, Yongin Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Yongin, Korea.

出版信息

Br J Dermatol. 2021 Jul;185(1):210-212. doi: 10.1111/bjd.19890. Epub 2021 Mar 31.

DOI:10.1111/bjd.19890
PMID:33657641
Abstract
摘要

相似文献

1
Mortality and clinical response of patients with bullous pemphigoid treated with rituximab.使用利妥昔单抗治疗的大疱性类天疱疮患者的死亡率和临床反应
Br J Dermatol. 2021 Jul;185(1):210-212. doi: 10.1111/bjd.19890. Epub 2021 Mar 31.
2
Refractory childhood pemphigoid successfully treated with rituximab.利妥昔单抗成功治疗难治性儿童类天疱疮。
Pediatr Dermatol. 2013 Sep-Oct;30(5):e96-7. doi: 10.1111/pde.12057. Epub 2012 Dec 28.
3
Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients.大疱性类天疱疮和黏膜类天疱疮对利妥昔单抗呈现混合反应：7例患者的经验
J Eur Acad Dermatol Venereol. 2011 Oct;25(10):1238-40. doi: 10.1111/j.1468-3083.2010.03889.x. Epub 2010 Nov 4.
4
A new approach on bullous pemphigoid therapy.
Ann Oncol. 2008 Apr;19(4):825-6. doi: 10.1093/annonc/mdn046. Epub 2008 Mar 5.
5
Treatment of bullous pemphigoid with rituximab: critical analysis of the current literature.利妥昔单抗治疗大疱性类天疱疮：当前文献的批判性分析
J Drugs Dermatol. 2013 Jun 1;12(6):672-7.
6
Remission of bullous pemphigoid after rituximab treatment in a psoriasis patient on regular low-dose methotrexate.一名接受常规低剂量甲氨蝶呤治疗的银屑病患者在使用利妥昔单抗治疗后大疱性类天疱疮缓解。
Acta Derm Venereol. 2014 Jan;94(1):108-9. doi: 10.2340/00015555-1619.
7
Refractory bullous pemphigoid with fatal outcome in a young patient.一名年轻患者出现难治性大疱性类天疱疮并导致致命后果。
Int J Dermatol. 2013 May;52(5):601-2. doi: 10.1111/j.1365-4632.2011.05317.x.
8
Association of serum B-cell activating factor level and proportion of memory and transitional B cells with clinical response after rituximab treatment of bullous pemphigoid patients.大疱性类天疱疮患者接受利妥昔单抗治疗后血清B细胞活化因子水平及记忆性和过渡性B细胞比例与临床反应的相关性
J Invest Dermatol. 2013 Dec;133(12):2786-2788. doi: 10.1038/jid.2013.236. Epub 2013 Jun 3.
9
[Bullous Pemphigoid Successfully Treated with Rituximab].
Acta Med Port. 2017 Mar 31;30(3):243-246. doi: 10.20344/amp.7812.
10
Rituximab for treatment-refractory pemphigus and pemphigoid: a case series of 17 patients.利妥昔单抗治疗难治性天疱疮和类天疱疮：17 例病例系列。
J Am Acad Dermatol. 2011 Sep;65(3):552-558. doi: 10.1016/j.jaad.2010.07.032.

引用本文的文献

1
Anti-interleukin 4 receptor α antibody for the treatment of Chinese bullous pemphigoid patients with diverse comorbidities and a 1-year follow-up: a monocentric real-world study.抗白细胞介素 4 受体 α 抗体治疗伴有多种合并症的中国大疱性类天疱疮患者：一项单中心真实世界研究。
Front Immunol. 2023 Jul 20;14:1165106. doi: 10.3389/fimmu.2023.1165106. eCollection 2023.
2
Retrospective analysis of the long-term therapeutic effectiveness and safety profile of rituximab in the treatment of mucous membrane pemphigoid in a German university center between 2008 and 2019.回顾性分析 2008 年至 2019 年期间在德国大学中心使用利妥昔单抗治疗黏膜类天疱疮的长期疗效和安全性。
Front Immunol. 2023 Apr 18;14:1180150. doi: 10.3389/fimmu.2023.1180150. eCollection 2023.
3
Understanding CD4 T cells in autoimmune bullous diseases.了解自身免疫性大疱性疾病中的 CD4 T 细胞。
Front Immunol. 2023 Apr 17;14:1161927. doi: 10.3389/fimmu.2023.1161927. eCollection 2023.
4
The cytokine milieu of bullous pemphigoid: Current and novel therapeutic targets.大疱性类天疱疮的细胞因子环境：当前及新的治疗靶点
Front Med (Lausanne). 2023 Feb 6;10:1128154. doi: 10.3389/fmed.2023.1128154. eCollection 2023.
5
Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin.抗 CD20 单克隆抗体治疗皮肤自身免疫性疾病的综述。
Am J Clin Dermatol. 2023 Mar;24(2):247-273. doi: 10.1007/s40257-022-00751-7. Epub 2023 Jan 11.
6
Case Report: Omalizumab Successfully Treated Recalcitrant Bullous Pemphigoid in an Elderly Patient with Multiple Comorbidities.病例报告：奥马珠单抗成功治疗一名患有多种合并症的老年患者的顽固性大疱性类天疱疮。
Clin Cosmet Investig Dermatol. 2022 Jul 21;15:1391-1396. doi: 10.2147/CCID.S373682. eCollection 2022.
7
Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients.利妥昔单抗治疗黏膜性类天疱疮：109 例患者的回顾性单中心研究及长期随访
Front Immunol. 2022 Jun 30;13:915205. doi: 10.3389/fimmu.2022.915205. eCollection 2022.
8
Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases.慢性非传染性炎症性皮肤病中未满足的医疗需求。
Front Med (Lausanne). 2022 Jun 9;9:875492. doi: 10.3389/fmed.2022.875492. eCollection 2022.
9
Clinical Effectiveness and Safety of Initial Combination Therapy with Corticosteroids and Rituximab in Bullous Pemphigoid: A Retrospective Cohort Study.大疱性类天疱疮初始激素联合利妥昔单抗治疗的临床疗效及安全性：一项回顾性队列研究。
Am J Clin Dermatol. 2022 Jul;23(4):571-585. doi: 10.1007/s40257-022-00688-x. Epub 2022 May 17.
10
Immunopathology and Immunotherapy of Inflammatory Skin Diseases.炎症性皮肤病的免疫病理学与免疫治疗
Immune Netw. 2022 Feb 14;22(1):e7. doi: 10.4110/in.2022.22.e7. eCollection 2022 Feb.